Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2019

Open Access 01-12-2019 | Coronary Heart Disease | Research article

Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine

Authors: Aya Barham, Reem Ibraheem, Sa’ed H. Zyoud

Published in: BMC Cardiovascular Disorders | Issue 1/2019

Login to get access

Abstract

Background

Psychological factors, such as self-efficacy, are important in understanding the progress and management of coronary heart disease (CHD), and how patients make lifestyle modifications to compensate for the disease. The main objectives of this research are to assess patterns of cardiac self-efficacy (CSE) and quality of life (QoL) among CHD patients, and to determine the factors that affect their QoL.

Methods

A cross-sectional descriptive correlational study was carried out between August 2016 and December 2016. We used a structured questionnaire completed by interviewers during face-to-face interviews with patients. Cardiac self-efficacy was evaluated using three scales: 1) the 5-item perceived efficacy in patient- physician interaction scale (PEPPI-5); 2) the self-efficacy for managing chronic diseases 6-item scale (SEMCD-6) and 3) Sullivan’s cardiac self-efficacy scale 13-items (SCSES). The 5-level version of the EuroQoL 5-dimensions questionnaire (EQ-5D-5 L), and Euroqol Visual Analogue Scale (EQ VAS) were used to evaluate health-related QoL (HRQoL) among CHD patients. Multiple binary logistic regression was carried out to evaluate the influence on the QoL score of demographic and medical characteristics, and self-efficacy factors.

Results

A total of 275 patients participated in our study. The patients’ mean age was 59.51 ± 1.005 years. The HRQoL was measured by the EQ-5D-5 L index score and EQ-VAS score; their means were 0.62 ± 0.16 and 57.44 ± 1.61, respectively. The QoL showed moderate positive correlations with the PEPPI-5 (r = 0.419; p-value < 0.001), SEMCD-6 (r = 0.419; p-value < 0.001), and SCSES score (r = 0.273; p-value < 0.001). Multiple binary logistic regression showed that only patients with higher PEPPI-5 score (odds ratio (OR) = 1.11; 95% confidence interval (CI) =1.01–1.22; p = 0.036), and higher SCSES score (OR = 1.10; 95% CI = 1.03–1.17; p = 0.004) were significantly associated with a high QoL score. Moreover, multiple binary logistic regression model showed that patients with higher numbers of medications (OR = 0.23; 95% CI = 0.07–0.78); p = 0.018) remained significantly associated with impaired QoL.

Conclusions

Lower levels of self-efficacy and poorer patient-physician interactions predicted poor HRQoL. Thus, health providers should be aware of these factors in CHD patients when trying to improve their QoL.
Literature
1.
go back to reference Song KJ. The effects of self-efficacy promoting cardiac rehabilitation program on self-efficacy, health behavior, and quality of life. Taehan Kanho Hakhoe Chi. 2003;33(4):510–8.PubMed Song KJ. The effects of self-efficacy promoting cardiac rehabilitation program on self-efficacy, health behavior, and quality of life. Taehan Kanho Hakhoe Chi. 2003;33(4):510–8.PubMed
2.
go back to reference Allahverdipour H, Asgharijafarabadi M, Heshmati R, Hashemiparast M. Functional status, anxiety, cardiac self-efficacy, and health beliefs of patients with coronary heart disease. Health Promot Perspect. 2013;3(2):217–29.PubMedPubMedCentral Allahverdipour H, Asgharijafarabadi M, Heshmati R, Hashemiparast M. Functional status, anxiety, cardiac self-efficacy, and health beliefs of patients with coronary heart disease. Health Promot Perspect. 2013;3(2):217–29.PubMedPubMedCentral
3.
go back to reference Poortaghi S, Baghernia A, Golzari SE, Safayian A, Atri SB. The effect of home-based cardiac rehabilitation program on self efficacy of patients referred to cardiac rehabilitation center. BMC Res Notes. 2013;6:287.PubMedPubMedCentralCrossRef Poortaghi S, Baghernia A, Golzari SE, Safayian A, Atri SB. The effect of home-based cardiac rehabilitation program on self efficacy of patients referred to cardiac rehabilitation center. BMC Res Notes. 2013;6:287.PubMedPubMedCentralCrossRef
4.
go back to reference Abu-Rmeileh NM, Shoaibi A, O'Flaherty M, Capewell S, Husseini A. Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009. BMJ Open. 2012;2(4):e001061.PubMedPubMedCentralCrossRef Abu-Rmeileh NM, Shoaibi A, O'Flaherty M, Capewell S, Husseini A. Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009. BMJ Open. 2012;2(4):e001061.PubMedPubMedCentralCrossRef
6.
go back to reference Kark JD, Fink R, Adler B, Goldberger N, Goldman S. The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int J Epidemiol. 2006;35(2):448–57.PubMedCrossRef Kark JD, Fink R, Adler B, Goldberger N, Goldman S. The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int J Epidemiol. 2006;35(2):448–57.PubMedCrossRef
7.
go back to reference O’Neil A, Berk M, Davis J, Stafford L. Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients. Health. 2013;05(07):6–14.CrossRef O’Neil A, Berk M, Davis J, Stafford L. Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients. Health. 2013;05(07):6–14.CrossRef
9.
go back to reference Saengsiri A-O, Thanasilp S, Preechawong S. Factors predicting quality of life for coronary artery disease patients after percutaneous coronary intervention. Asian Biomedicine. 2014;8(1):31–42.CrossRef Saengsiri A-O, Thanasilp S, Preechawong S. Factors predicting quality of life for coronary artery disease patients after percutaneous coronary intervention. Asian Biomedicine. 2014;8(1):31–42.CrossRef
11.
go back to reference Beng KS. The last hours and days of life: a biopsychosocial-spiritual model of care. Asia Pac Fam Med. 2004;4:1–3. Beng KS. The last hours and days of life: a biopsychosocial-spiritual model of care. Asia Pac Fam Med. 2004;4:1–3.
12.
go back to reference Daaleman TP, Elder GH Jr. Family medicine and the life course paradigm. J Am Board Fam Med. 2007;20(1):85–92.PubMedCrossRef Daaleman TP, Elder GH Jr. Family medicine and the life course paradigm. J Am Board Fam Med. 2007;20(1):85–92.PubMedCrossRef
13.
go back to reference Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292.PubMed Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–e292.PubMed
14.
go back to reference Zachariah G, Harikrishnan S, Krishnan MN, Mohanan PP, Sanjay G, Venugopal K, Thankappan KR. Prevalence of coronary artery disease and coronary risk factors in Kerala, South India: a population survey - design and methods. Indian Heart J. 2013;65(3):243–9.PubMedPubMedCentralCrossRef Zachariah G, Harikrishnan S, Krishnan MN, Mohanan PP, Sanjay G, Venugopal K, Thankappan KR. Prevalence of coronary artery disease and coronary risk factors in Kerala, South India: a population survey - design and methods. Indian Heart J. 2013;65(3):243–9.PubMedPubMedCentralCrossRef
15.
go back to reference Suwatanaviroj T, Yamwong S. Prevalence of coronary artery disease in different ethnic groups at a tertiary care hospital. J Med Assoc Thail. 2013;96(10):1298–301. Suwatanaviroj T, Yamwong S. Prevalence of coronary artery disease in different ethnic groups at a tertiary care hospital. J Med Assoc Thail. 2013;96(10):1298–301.
16.
go back to reference Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.PubMedCrossRef Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.PubMedCrossRef
17.
go back to reference Henselmans I, Heijmans M, Rademakers J, van Dulmen S. Participation of chronic patients in medical consultations: patients’ perceived efficacy, barriers and interest in support. Health Expect. 2015;18(6):2375–88.PubMedCrossRef Henselmans I, Heijmans M, Rademakers J, van Dulmen S. Participation of chronic patients in medical consultations: patients’ perceived efficacy, barriers and interest in support. Health Expect. 2015;18(6):2375–88.PubMedCrossRef
19.
go back to reference Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The cardiac self-efficacy scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. 2015;14(6):536–43.PubMedCrossRef Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The cardiac self-efficacy scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. 2015;14(6):536–43.PubMedCrossRef
20.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.PubMedPubMedCentralCrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.PubMedPubMedCentralCrossRef
22.
go back to reference Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R. Relationship of treatment satisfaction to health-related quality of life: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Expect. 2015;18(6):3336–48.PubMedCrossRef Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R. Relationship of treatment satisfaction to health-related quality of life: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Expect. 2015;18(6):3336–48.PubMedCrossRef
23.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R, Morisky DE. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. Int J Cardiol. 2013;168(3):2981–3.PubMedCrossRef Zyoud SH, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R, Morisky DE. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. Int J Cardiol. 2013;168(3):2981–3.PubMedCrossRef
24.
go back to reference Zyoud SH, Daraghmeh DN, Mezyed DO, Khdeir RL, Sawafta MN, Ayaseh NA, Tabeeb GH, Sweileh WM, Awang R, Al-Jabi SW. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrol. 2016;17(1):44.PubMedPubMedCentralCrossRef Zyoud SH, Daraghmeh DN, Mezyed DO, Khdeir RL, Sawafta MN, Ayaseh NA, Tabeeb GH, Sweileh WM, Awang R, Al-Jabi SW. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrol. 2016;17(1):44.PubMedPubMedCentralCrossRef
25.
go back to reference Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R. Assessment of health-related quality of life among hypertensive patients: a cross-sectional study from Palestine. J Public Health. 2014;22(3):277–86.CrossRef Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, Badwan MA, Awang R. Assessment of health-related quality of life among hypertensive patients: a cross-sectional study from Palestine. J Public Health. 2014;22(3):277–86.CrossRef
26.
go back to reference Zyoud SH, Awang R, Sulaiman SA, Al-Jabi SW. An analysis of the length of hospital stay after acetaminophen overdose. Hum Exp Toxicol. 2011;30(7):550–9.PubMedCrossRef Zyoud SH, Awang R, Sulaiman SA, Al-Jabi SW. An analysis of the length of hospital stay after acetaminophen overdose. Hum Exp Toxicol. 2011;30(7):550–9.PubMedCrossRef
27.
go back to reference Aga Z, Machina M, McCluskey SA. Greater intravenous fluid volumes are associated with prolonged recovery after colorectal surgery: a retrospective cohort study. Br J Anaesth. 2016;116(6):804–10.PubMedCrossRef Aga Z, Machina M, McCluskey SA. Greater intravenous fluid volumes are associated with prolonged recovery after colorectal surgery: a retrospective cohort study. Br J Anaesth. 2016;116(6):804–10.PubMedCrossRef
29.
go back to reference Wang L, Wu YQ, Tang X, Li N, He L, Cao Y, Chen DF, Hu YH. Profile and correlates of health-related quality of life in Chinese patients with coronary heart disease. Chin Med J. 2015;128(14):1853–61.PubMedPubMedCentralCrossRef Wang L, Wu YQ, Tang X, Li N, He L, Cao Y, Chen DF, Hu YH. Profile and correlates of health-related quality of life in Chinese patients with coronary heart disease. Chin Med J. 2015;128(14):1853–61.PubMedPubMedCentralCrossRef
30.
go back to reference Tusek-Bunc K, Petek D. Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of life. Health Qual Life Outcomes. 2016;14(1):159.PubMedPubMedCentralCrossRef Tusek-Bunc K, Petek D. Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of life. Health Qual Life Outcomes. 2016;14(1):159.PubMedPubMedCentralCrossRef
31.
go back to reference Gencer B, Rodondi N, Auer R, Nanchen D, Raber L, Klingenberg R, Pletscher M, Juni P, Windecker S, Matter CM, et al. Health utility indexes in patients with acute coronary syndromes. Open Heart. 2016;3(1):e000419.PubMedPubMedCentralCrossRef Gencer B, Rodondi N, Auer R, Nanchen D, Raber L, Klingenberg R, Pletscher M, Juni P, Windecker S, Matter CM, et al. Health utility indexes in patients with acute coronary syndromes. Open Heart. 2016;3(1):e000419.PubMedPubMedCentralCrossRef
32.
go back to reference Zyoud SH, Al-Jabi SW, Sweileh WM, Arandi DA, Dabeek SA, Esawi HH, Atyeh RH, Abu-Ali HA, Sleet YI, Abd-Alfatah BM, et al. Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: findings from a cross-sectional study. J Clin Transl Endocrinol. 2015;2(2):66–71.PubMedPubMedCentral Zyoud SH, Al-Jabi SW, Sweileh WM, Arandi DA, Dabeek SA, Esawi HH, Atyeh RH, Abu-Ali HA, Sleet YI, Abd-Alfatah BM, et al. Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus: findings from a cross-sectional study. J Clin Transl Endocrinol. 2015;2(2):66–71.PubMedPubMedCentral
33.
go back to reference Sarkar U, Ali S, Whooley MA. Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med. 2007;69(4):306–12.PubMedPubMedCentralCrossRef Sarkar U, Ali S, Whooley MA. Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med. 2007;69(4):306–12.PubMedPubMedCentralCrossRef
34.
go back to reference Brink E, Alsen P, Herlitz J, Kjellgren K, Cliffordson C. General self-efficacy and health-related quality of life after myocardial infarction. Psychol Health Med. 2012;17(3):346–55.PubMedCrossRef Brink E, Alsen P, Herlitz J, Kjellgren K, Cliffordson C. General self-efficacy and health-related quality of life after myocardial infarction. Psychol Health Med. 2012;17(3):346–55.PubMedCrossRef
35.
go back to reference Sarkar U, Ali S, Whooley MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the heart and soul study. Health Psychol. 2009;28(2):166–73.PubMedPubMedCentralCrossRef Sarkar U, Ali S, Whooley MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the heart and soul study. Health Psychol. 2009;28(2):166–73.PubMedPubMedCentralCrossRef
36.
go back to reference Sardu C, Paolisso P, Sacra C, Mauro C, Minicucci F, Portoghese M, Rizzo MR, Barbieri M, Sasso FC, D'Onofrio N, et al. Effects of metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE multicenter prospective study. Diabetes Care. 2019;42(10):1946–55.PubMedCrossRef Sardu C, Paolisso P, Sacra C, Mauro C, Minicucci F, Portoghese M, Rizzo MR, Barbieri M, Sasso FC, D'Onofrio N, et al. Effects of metformin therapy on coronary endothelial dysfunction in patients with prediabetes with stable angina and nonobstructive coronary artery stenosis: the CODYCE multicenter prospective study. Diabetes Care. 2019;42(10):1946–55.PubMedCrossRef
37.
go back to reference Marfella R, Sardu C, Calabro P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, et al. Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: effects of incretin treatment. Diabetes Obes Metab. 2018;20(3):723–9.PubMedCrossRef Marfella R, Sardu C, Calabro P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, et al. Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: effects of incretin treatment. Diabetes Obes Metab. 2018;20(3):723–9.PubMedCrossRef
38.
go back to reference Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabro P, Mauro C, Pieretti G, Coppola A, et al. Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis. Diabetol Metab Syndr. 2018;10:1.PubMedPubMedCentralCrossRef Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabro P, Mauro C, Pieretti G, Coppola A, et al. Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis. Diabetol Metab Syndr. 2018;10:1.PubMedPubMedCentralCrossRef
39.
go back to reference Sasso FC, Pafundi PC, Marfella R, Calabro P, Piscione F, Furbatto F, Esposito G, Galiero R, Gragnano F, Rinaldi L, et al. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE study. Cardiovasc Diabetol. 2019;18(1):24.PubMedPubMedCentralCrossRef Sasso FC, Pafundi PC, Marfella R, Calabro P, Piscione F, Furbatto F, Esposito G, Galiero R, Gragnano F, Rinaldi L, et al. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE study. Cardiovasc Diabetol. 2019;18(1):24.PubMedPubMedCentralCrossRef
40.
go back to reference Sardu C, D'Onofrio N, Torella M, Portoghese M, Loreni F, Mureddu S, Signoriello G, Scisciola L, Barbieri M, Rizzo MR, et al. Pericoronary fat inflammation and major adverse cardiac events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Cardiovasc Diabetol. 2019;18(1):126.PubMedPubMedCentralCrossRef Sardu C, D'Onofrio N, Torella M, Portoghese M, Loreni F, Mureddu S, Signoriello G, Scisciola L, Barbieri M, Rizzo MR, et al. Pericoronary fat inflammation and major adverse cardiac events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Cardiovasc Diabetol. 2019;18(1):126.PubMedPubMedCentralCrossRef
41.
go back to reference Bandura A. Self-efficacy: the exercise of control. New York: W H Freeman/Times Books/ Henry Holt & Co; 1997. Bandura A. Self-efficacy: the exercise of control. New York: W H Freeman/Times Books/ Henry Holt & Co; 1997.
42.
go back to reference Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–49.PubMedCrossRef Sullivan PW, Lawrence WF, Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care. 2005;43(7):736–49.PubMedCrossRef
43.
44.
go back to reference Jiang Y, Hesser JE. Associations between health-related quality of life and demographics and health risks. Results from Rhode Island’s 2002 behavioral risk factor survey. Health Qual Life Outcomes. 2006;4(1):14.PubMedPubMedCentralCrossRef Jiang Y, Hesser JE. Associations between health-related quality of life and demographics and health risks. Results from Rhode Island’s 2002 behavioral risk factor survey. Health Qual Life Outcomes. 2006;4(1):14.PubMedPubMedCentralCrossRef
45.
go back to reference Tuzun H, Aycan S, Ilhan MN. Impact of comorbidity and socioeconomic status on quality of life in patients with chronic diseases who attend primary health care centres. Cent Eur J Public Health. 2015;23(3):188–94.PubMedCrossRef Tuzun H, Aycan S, Ilhan MN. Impact of comorbidity and socioeconomic status on quality of life in patients with chronic diseases who attend primary health care centres. Cent Eur J Public Health. 2015;23(3):188–94.PubMedCrossRef
Metadata
Title
Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine
Authors
Aya Barham
Reem Ibraheem
Sa’ed H. Zyoud
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2019
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-019-01281-7

Other articles of this Issue 1/2019

BMC Cardiovascular Disorders 1/2019 Go to the issue